Central Pharmaceutical JSC No. 3
UUPCOM:TW312,000.00
VND
-1,000.00
(-7.69%)
ISIN
VN000000TW39
Return %
Stock
S&P 500
1Y
-23.08
14.20
3Y
-7.69
81.12
5Y
-52.00
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- Sector
- Health technology
- Industry
- Pharmaceuticals: major
- Address
- Da Nang Vietnam
- Website
- duoctw3.com
- Similar Companies
- Business
- Central Pharmaceutical Joint Stock Company No. 3 (UPCoM: TW3), commonly known as Foripharm, is a Vietnam-based pharmaceutical company primarily engaged in the research, development, manufacture, processing, trading, import, and export of pharmaceuticals, traditional herbal medicines, health supplements, and medical supplies. The company operates across three main business segments: Traditional Herbal Medicines, Modern Pharmaceuticals, and Dietary Supplements and Healthcare Products. Its product portfolio comprises traditional and herbal therapeutics, including kidney and vitality tonics under the Sam Nhung Bo Than TW3 brand, cerebral circulation enhancers under the Hoat Huyet Duong Nao TW3 brand, and herbal cough preparations under the Bo Phe TW3 brand; medicated ointments and aromatic balms, notably Golden Star Balm (Cao Sao Vang); modern generic prescription and over-the-counter pharmaceuticals, including antibiotics, anti-inflammatory drugs, analgesics, antipyretics, cardiovascular treatments, gastrointestinal medicines, and antihistamines; dietary and health supplements, including multivitamins, minerals, and functional herbal extracts; and pharmaceutical ingredients, packaging materials, and medical devices. The company manufactures its formulations across multiple dosage formats, including hard and soft capsules, film-coated tablets, effervescent granules, oral solutions, syrups, ointments, and balms, utilizing production lines certified under World Health Organization Good Manufacturing Practice (WHO-GMP), Good Laboratory Practice (GLP), and Good Storage Practice (GSP) standards. Central Pharmaceutical Joint Stock Company No. 3 serves domestic hospital systems, medical clinics, regional distributors, and retail pharmacy chains through a nationwide distribution network supported by branches in Hanoi, Da Nang, and Ho Chi Minh City, while also exporting traditional remedies and medicated balms to international markets in Eastern Europe, Russia, and Southeast Asia. In recent operational developments, the company has upgraded its WHO-GMP certified manufacturing lines to increase output capacity for high-demand modern formulations and dietary supplements, expanded its commercial partnerships with national pharmacy retail chains and e-commerce distribution platforms, and advanced supply chain integration by investing in standardized domestic medicinal herb cultivation initiatives. Central Pharmaceutical Joint Stock Company No. 3 was founded in 1962 and is headquartered in Hai Phong, Vietnam.